$CRTX CORNERSTONE THERAPEUTICS INC Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CORNERSTONE THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in CORNERSTONE THERAPEUTICS INC. Find out how many shares they currently own, their value and whether they buy or sell their shares.
CORNERSTONE THERAPEUTICS INC Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| ADVANCED TECHNOLOGY VENTURES VII LP | 10% Owner | 27,275 | 0 | Jun 22 2005 | |||
| Baldwin Chenyqua Michele | Vice President Finance | 178,562 | 0 | Nov 04 2008 | |||
| Chiesi Alessandro | Director | 0 | 0 | May 23 2012 | |||
| Chiesi Farmaceutici SpA | 10% Owner | 10,000 | 0 | Feb 04 2014 | |||
| CODEANNE CHRISTOPHER GEORGE | Director | 0 | 0 | Feb 04 2014 | |||
| Collard Craig A | President and CEO | 4,646,138 | 0 | Nov 04 2008 | |||
| Collard Craig A | Chief Executive Officer | 0 | 0 | Feb 04 2014 | |||
| Cornerstone Biopharma Holdings, Ltd. | 10% Owner | 1,952,225 | 0 | Jul 30 2009 | |||
| Dickson Brian | Chief Medical Officer | 0 | 0 | Nov 04 2008 | |||
| Dickson Brian | Chief Medical Officer | 0 | 0 | Sep 03 2009 | |||
| Duarte Ira | Principal Accounting Officer | 7,000 | 0 | Mar 11 2013 | |||
| Duarte Ira | Principal Accounting Officer | 0 | 0 | Feb 04 2014 | |||
| DUGAN RICHARD W | Director | 0 | 0 | May 03 2007 | |||
| Enright Michael David | Director | 0 | 0 | Feb 04 2014 | |||
| Esgro George Arthur | Vice President Sales | 0 | 0 | Nov 04 2008 | |||
| EVNIN LUKE | 7,226 | 0 | Feb 15 2007 | ||||
| Failla Anton Giorgio | Director | 0 | 0 | Feb 04 2014 | |||
| Finnegan Frederick | SVP of Sales and Marketing | 40,406 | 0 | Jan 04 2006 | |||
| Franklin Joshua B | VP, Strategy & Bus. Dev. | 0 | 0 | Feb 04 2014 | |||
| GADICKE ANSBERT | 1,204 | 0 | Feb 15 2007 | ||||
| GALAKATOS NICHOLAS | Director | 4,845,877 | 0 | Jun 22 2005 | |||
| GALAKATOS NICHOLAS | Director | 289 | 0 | Feb 15 2007 | |||
| George Jean | Director | 1,904,759 | 0 | Sep 20 2004 | |||
| George Jean | Director | 27,275 | 0 | Jun 22 2005 | |||
| George Jean | Director | 0 | 0 | Apr 25 2006 | |||
| George Jean | Director | 0 | 0 | May 03 2007 | |||
| Harper James A | Director | 0 | 0 | May 23 2013 | |||
| Harper James A | Director | 0 | 0 | Feb 04 2014 | |||
| HEALTHCARE VENTURES VI LP | 10% Owner | 4,058,432 | 0 | Jun 02 2004 | |||
| Heffernan Michael Thomas | Director | 0 | 0 | Feb 04 2014 | |||
| Heffernan Michael Thomas | Director | 0 | 0 | Nov 04 2008 | |||
| Hilt Dana Charles | SVP of Clinical Develop. & CMO | 26,700 | 0 | Dec 29 2006 | |||
| JOHNSON & JOHNSON | 10% Owner | 2,104,704 | 0 | Jun 02 2004 | |||
| Kelly Thomas Patrick | CFO & SVP Finance & Corp. Dev, | 90,700 | 0 | Feb 19 2008 | |||
| Lutz Steven Michael | Executive Vice President | 677,348 | 0 | Nov 04 2008 | |||
| Lutz Steven Michael | Executive Vice President | 262,348 | 0 | Mar 04 2011 | |||
| Maetzel Andreas | VP, Clinical and Regulatory | 25,000 | 0 | May 07 2013 | |||
| Maetzel Andreas | VP, Clinical and Regulatory | 0 | 0 | Feb 04 2014 | |||
| McBean Kenneth | President | 83,705 | 0 | Mar 07 2013 | |||
| McBean Kenneth | President | 0 | 0 | Feb 04 2014 | |||
| MCEWAN ALASTAIR STUART | Director | 0 | 0 | Nov 04 2008 | |||
| MCEWAN ALASTAIR STUART | CFO and Treasurer | 0 | 0 | Feb 04 2014 | |||
| MedImmune Ventures, Inc. | 10% Owner | 2,857,142 | 0 | Jun 04 2004 | |||
| MIRAELLI CHRISTOPHER | Director | 5,153,323 | 0 | Jun 21 2005 | |||
| Morgus Vincent T. | EVP, Finance and CFO | 49,644 | 0 | Aug 24 2012 | |||
| MPM BIOVENTURES II QP LP | 10% Owner | 4,845,877 | 0 | Jun 22 2005 | |||
| MPM BIOVENTURES II QP LP | 3,845,876 | 0 | Feb 14 2007 | ||||
| MPM BIOVENTURES III QP LP | 10% Owner | 4,298,430 | 0 | Jun 02 2004 | |||
| Newman Walter | Chief Scientific Officer/VP RD | 13,332 | 0 | Jun 03 2004 | |||
| Newman Walter | CSO/SVP Research & Development | 0 | 0 | Jun 27 2006 | |||
| Phillips Trevor | Former President & CEO | 7,754 | 0 | Nov 04 2008 | |||
| Powell Andrew Kenneth William | EVP, General Counsel | 89,785 | 0 | Aug 30 2013 | |||
| Price David | Chief Financial Officer | 325,133 | 0 | Nov 04 2008 | |||
| Price David | Chief Financial Officer | 175,133 | 0 | Mar 09 2010 | |||
| Roberts Alan | VP, Scientific Affairs | 80,947 | 0 | Mar 07 2013 | |||
| Roberts Alan | VP, Scientific Affairs | 0 | 0 | Feb 04 2014 | |||
| RUBIN PAUL D | President and CEO | 114,303 | 0 | Mar 22 2006 | |||
| Shawver Laura | Director | 0 | 0 | May 23 2013 | |||
| Shawver Laura | Director | 0 | 0 | Feb 04 2014 | |||
| STEINMETZ MICHAEL | 723 | 0 | Feb 15 2007 | ||||
| Stephan Robert | Director | 0 | 0 | Feb 04 2014 | |||
| TANANBAUM JAMES B | Director | 0 | 0 | Jun 18 2007 | |||
| THOMAS FRANK E | President & CEO | 72,033 | 0 | Aug 22 2007 | |||
| Townsend Scott B | GENERAL COUNSEL and SVP LEGAL | 94,868 | 0 | Feb 19 2008 | |||
| Townsend Scott B | GENERAL COUNSEL and EVP LEGAL | 158,015 | 0 | Nov 04 2008 | |||
| Townsend Scott B | GENERAL COUNSEL and EVP LEGAL | 113,043 | 0 | May 18 2009 | |||
| Vecchia Marco | Director | 0 | 0 | Feb 04 2014 | |||
| WALSH CHRISTOPHER T PHD | Director | 10,991 | 0 | May 03 2007 | |||
| Warren Howland Shaw | Director | 224,600 | 0 | Apr 26 2006 | |||
| WHEELER KURT | 452 | 0 | Feb 15 2007 | ||||
| Young Jeffrey E | FORMER VP FINANCE & CAO | 5,053 | 0 | Nov 14 2008 | |||
| Zeiger Robert H | Director | 0 | 0 | May 03 2007 | |||
| Zwerling M Cory | Director | 0 | 0 | May 03 2007 |